Skip to content
Find coverage of Northeastern University in the press.
The Boston Globe logo.

Supreme Court to review juvenile injustice

Tomorrow morning, the justices of the U.S. Supreme Court will hear oral arguments in two cases, Jackson v. Hobbs and Miller v. Alabama, challenging the controversial practice of sentencing juvenile offenders to life imprisonment without the possibility of parole.
The Boston Globe logo.

Once a model, state medical board lags badly

In 2005, a Suffolk County jury decided that Dr. Mary Ames-Castro and another obstetrician caused irreversible brain damage to an infant girl during a delivery at Massachusetts General Hospital. The $23.8 million malpractice judgment was one of the largest in state history.
World Politics Review

Global Insider: Unrest in France’s DOM-TOM Has Its Limits

Riots broke out on the French island of Reunion last month over oil prices and the cost of living. In an email interview, William Miles, a professor of political science at Northeastern University, discussed the political and economic status of France’s overseas departments and territories, known as DOM-TOM.
The Republican

Investigation: Massachusetts medical board omits, removes thousands of embarrassing records from physician database

Sixteen years ago, it appeared that Dr. Scott S. Reuben, an anesthesiologist at Baystate Medical Center in Springfield, had found the holy grail of pain management.
The Washington Post Logo

Many seem willing to cut Afghan shooting suspect some slack; ‘good guy in the wrong place’

He is accused of the kind of crime that makes people shiver, the killing of families in their own homes under cover of night, the butchery of defenseless children. Under normal circumstances, Americans would dismiss such an act as worthy of only one response: swift and merciless punishment.
Hartford Courant

Acquitted For Insanity, Man Sues State Saying He Never Was Insane

A man acquitted of an attempted-murder charge by reason of insanity after an armed standoff with police is now suing the state, saying his confinement at Connecticut Valley Hospital for six years was illegal because he was never insane.
The Boston Globe logo.

Boston’s young talent getting easier access to internships and jobs

As someone who teaches college students, I am reminded daily of the importance of helping them find meaningful work with internships, co-ops and jobs. I gather whatever info I can and pass the opportunities along to my current and former students. Thankfully, there are some other people in Boston who have been focusing on this […]
New Scientist logo

Friday Illusion: Star Trek effect beams triple trick

No, it’s not science fiction: a new illusion that looks like a flight through space simultaneously tricks your brain in three different ways.
Trend

Iran announces bogus data to cover up its loss production capabilities – expert

The reason for Iran’s Oil Ministry announcing bogus data regarding its natural gas and oil production is to cover up its loss of production capabilities, U.S. Northeastern University Professor Kamran Dadkhah told Trend.
The Boston Globe logo.

Boston’s public schools shelve €˜pink slime

Hamburgers, taco meat, meatballs, and Salisbury steak – all products made with ground beef – have been temporarily stricken from lunch menus in Boston’€™s public schools as the district awaits word from the federal government about the presence of pink slime.
Associated Press Logo

Study: Young people not so ‘green’ after all

They have a reputation for being environmentally minded do-gooders. But an academic analysis of surveys spanning more than 40 years has found that today’s young Americans are less interested in the environment and in conserving resources -€” and often less civic-minded overall — than their elders were when they were young.
Mass High Tech

Biogen Idec and MAKScientific team up on MS drug candidates

MAKScientific, LLC, a privately held company in Boston focused on the discovery of novel therapeutics modulating cannabinoid pathways, today announced that it has entered into an exclusive option and collaboration agreement with Biogen Idec (NASDAQ: BIIB) to develop and commercialize drug candidates for the treatment of multiple sclerosis (MS) and other neurodegenerative diseases.